Dingliang Zhu Selected Research

Dingliang Zhu Research Topics

Disease

17	Hypertension (High Blood Pressure) 12/2018 - 06/2005
9	Essential Hypertension 02/2014 - 05/2002
7	Stroke (Strokes) 01/2019 - 09/2014
4	Pathologic Constriction (Stenosis) 01/2019 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2013
2	Ischemic Stroke 04/2015 - 01/2015
2	Cognitive Dysfunction 09/2014 - 09/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013 - 05/2012
2	Diabetes Mellitus 01/2013 - 07/2012
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 12/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Vascular Diseases (Vascular Disease) 12/2016
1	Hyperaldosteronism (Conn Syndrome) 09/2016
1	Inflammation (Inflammations) 01/2014
1	Vascular Ring 01/2014
1	Edema (Dropsy) 01/2014
1	Left Ventricular Dysfunction 03/2013
1	Obesity 02/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2013
1	Atherosclerotic Plaque (Atheroma) 02/2013
1	Atherosclerosis 02/2013
1	Chronic Renal Insufficiency 02/2012
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Breast Neoplasms (Breast Cancer) 11/2010
1	Glucose Intolerance 08/2010
1	Insulin Resistance 08/2010
1	Type 2 Diabetes Mellitus (MODY) 01/2010

Drug/Important Bio-Agent (IBA)

9	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 06/2005
5	Telmisartan (Micardis)FDA Link 06/2014 - 01/2013
3	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 06/2014 - 01/2013
2	AlbuminsIBA 01/2019 - 02/2012
2	CreatinineIBA 01/2019 - 02/2012
2	HomocysteineIBA 12/2018 - 08/2016
2	LDL CholesterolIBA 09/2014 - 09/2014
2	oxidized low density lipoproteinIBA 09/2014 - 09/2014
2	Amlodipine (Norvasc)FDA LinkGeneric 02/2014 - 01/2014
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2014 - 05/2002
2	Receptor for Advanced Glycation End ProductsIBA 01/2013 - 07/2012
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018
1	lysophosphatidic acidIBA 01/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2016
1	PotassiumIBA 09/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2015
1	Enalapril FDA LinkGeneric 04/2015
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2015
1	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 06/2014
1	arotinolol (S 596)IBA 01/2014
1	arginine methyl esterIBA 01/2014
1	CollagenIBA 01/2014
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2014
1	Valsartan (Vals)FDA Link 09/2013
1	Valsartan Drug Combination Amlodipine FDA Link 09/2013
1	Mineralocorticoid Receptor AntagonistsIBA 03/2013
1	plasmin receptorIBA 02/2013
1	Fibrinolysin FDA Link 02/2013
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2013
1	AdipokinesIBA 02/2013
1	LipidsIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Interleukin-6 (Interleukin 6)IBA 05/2012
1	NAD (NADH)IBA 01/2012
1	NADP (NADPH)IBA 01/2012
1	Oxidoreductases (Dehydrogenase)IBA 01/2012
1	quinone (benzoquinone)IBA 01/2012
1	kynureninaseIBA 12/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2010
1	Ligases (Synthetase)IBA 10/2010
1	ApelinIBA 09/2010
1	Glucose (Dextrose)FDA LinkGeneric 08/2010
1	Bradykinin B2 ReceptorIBA 03/2010
1	CatalaseIBA 03/2010
1	ReninIBA 01/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2010
1	Apolipoproteins E (ApoE)IBA 12/2009
1	Apolipoprotein E4IBA 12/2009
1	ORALIT (ORS)IBA 12/2009
1	Apolipoprotein E3IBA 12/2009
1	ApolipoproteinsIBA 12/2009
1	Apolipoprotein E2IBA 12/2009
1	CytokinesIBA 06/2002
1	Endothelins (Endothelin)IBA 05/2002
1	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2002

Therapy/Procedure

5	Therapeutics 04/2015 - 01/2013
1	Adrenalectomy 09/2016
1	Duration of Therapy 04/2015
1	Secondary Prevention 09/2014